Marcus Clark, M.D.
Molecular Mechanisms by which B Cell Antigen Receptors
Couple to/Activate Tyrosine Kinases
Research Summary
B-cells express a cell surface receptor (BCR) which
recognizes antigen. The receptor is composed of a clonotypic antigen
recognition substructure, membrane bound immunoglobulin, which is
noncovalently associated with disulfide linked products of the mb-1
(Ig-alpha) and B29 (Ig alpha) genes. Depending upon the developmental
stage of the cell and the context in which stimulation occurs, antigen
receptor engagement can elicit a myriad of phenotypic changes including
cell activation, anergy or cell death. These divergent biologic
responses are triggered by a BCR initiated cascade of intracellular
events.
Currently, our laboratory is pursuing three lines of
investigations.
1. To identify the biochemical mechanisms by which the
BCR couples to distal signaling pathways. Recently, we have
demonstrated that the direct recruitment of BLNK to a specific tyrosine
in Ig alpha couples the receptor to several distal signaling pathways.
2. To define the role of Ig alpha, Ig alpha and distal
signaling molecules in B cell development. We are pursuing these
questions using retroviral vectors to complement mice deficient in
specific transcription or signaling molecules important for B cell
development.
3. The molecular mechanisms of BCR intracellular trafficking. Our
recent work indicates that the recruitment of specific signaling
molecules insures proper sorting through the endocytic pathway and the
delivery of antigen to specialized antigen processing compartments.
These finding may be of importance for understanding how tolerance is
maintained and autoimmunity is prevented.
Selected Papers
Siemasko K, Eisfelder BJ, Brown B, Stebbins C, Kabak S,
Sant A, Song W, Clark MR. (1999). Ig alpha and Ig beta are required for
efficient trafficking to late endosomes and to enhance antigen
presentation. J. Immunol.162: 6518-6525.
Garrett-Sinha LA, Su GH, Rao S, Kabak S, Hao Z, Clark
MR, Simon MC. (1999). PU.1 and Spi-B are required for normal B cell
(BCR)-mediated signal transduction. Immunity 10(4):399-408.
Siemasko K and Clark MR. (2001). Regulation of MHC-class
II-restricted antigen processing. Curr. Opin. Immunol. 13:32-36.
Hu C-J, Rao S, Ramirez-Bergeron D.L., Garrett-Sinha LA,
Gerondakis S, Clark MR and Simon MC. (2001). PU.1 and Spi-B regulate
c-rel. Immunity. 15:545-555.
Siemasko K, Skaggs B, Kabak S, West Williamson E, Brown
B, Song W and Clark MR. (2002). B cell antigen receptor trafficking to
MIIC proceeds through sequential Ig alpha dependent targeting and
fusion checkpoints. J. Immunol. 168:2127-2138.
Sun T, Clark MR, and Storb U. (2002). A point mutation
in
the constant region of Ig lambda1 prevents normal B cell development
due to defective BCR signaling. Immunity 16(2):245-257.
Kabak S, Skaggs B, Gold MR, Affolter M, West K, Foster
M, Siemasko K, Chan AC, Aebersold R and Clark MR. (2002). The direct
recruitment of BLNK to Ig alpha couples the BCR to distal signaling
pathways. Mol. Cell. Biol. 22(8):2524-2535.
Li C, Siemasko K, Clark MR and Song W. (2002).
Efficiency
of antigen processing is dependent on the kinetics and specificity of
antigen. Int. Immunology 14:1179-1191.
Wang, LD and Clark, MR. (2003). B-cell antigen-receptor
signalling in lymphocyte development. Immunology110:411-420.
Wang, LD, Lopez J. Cooper AB, Dang-Lawson M, Matsuuchi L
and Clark MR. (2004). Selection of B lyphocytes in the periphery is
determined by the funtional capacity of the B cell antigen recptor.
Proc. Natl. Acad. Sci. 101:1027-1032.
Clark, MR, Massenburg, D., Siemasko, K, Hou, P., Zhang,
M. (2004). B-cell antigen receptor signaling requirements for targeting
antigen to the MHC class II presentation pathway. Curr Opin Immunol
16:382-387.
Zhang M, Massenburg D, and Clark MR. (2004). B-cell
antigen receptor
signaling requirements for targeting antigen to the MHC class II
presentation pathway, Curr. Opin Immunology 16:382-387.
Skaggs BJ and Clark MR. (2004). Proximal B cell receptor
signaling pathways: A review. Signal Transduction 5:173-194
|